Gorlick, Richard

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

Koirala, P., Roth, M. E., Gill, J., Chinai, J. M., Ewart, M. R., Piperdi, S., Geller, D. S., Hoang, B. H., Fatakhova, Y. V., Ghorpade, M., et al. (2016) · Scientific Reports

Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 100

Elevated Physiologic Tumor Pressure Promotes Proliferation and Chemosensitivity in Human Osteosarcoma

Nathan, S. S., DiResta, G. R., Casas-Ganem, J. E., Hoang, B. H., Sowers, R., Yang, R., Huvos, A. G., Gorlick, R., & Healey, J. H. (2005) · Clinical Cancer Research

Sarcoma Diagnosis and TreatmentCancer Cells and Metastasis

Cited by 85

Quality of Life Following Amputation or Limb Preservation in Patients with Lower Extremity Bone Sarcoma

Mason, G. E., Aung, L., Gall, S., Meyers, P. A., Butler, R., Krüg, S., Kim, M., Healey, J. H., & Gorlick, R. (2013) · Frontiers in Oncology

Sarcoma Diagnosis and TreatmentCancer survivorship and care

Cited by 81

Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis

Murphy, B., Yin, H., Maris, J. M., Kolb, E. A., Gorlick, R., Reynolds, C. P., Kang, M. H., Keir, S. T., Kurmasheva, R. T., Dvorchik, I., et al. (2016) · Cancer Research

Animal testing and alternativesCancer Cells and Metastasis

Cited by 69

Detection of circulating tumor DNA in patients with osteosarcoma

Barris, D. M., Weiner, S. B., Dubin, R. A., Fremed, M., Zhang, X., Piperdi, S., Zhang, W., Maqbool, S., Gill, J., Roth, M., et al. (2018) · Oncotarget

Cancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment

Cited by 63

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee

Bishop, M. W., Chang, Y., Krailo, M. D., Meyers, P. A., Provisor, A. J., Schwartz, C. L., Marina, N. M., Teot, L. A., Gebhardt, M. C., Gorlick, R., et al. (2016) · Pediatric Blood & Cancer

Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments

Cited by 52

Cell Proliferation of Cultured Human Cancer Cells are Affected by the Elevated Tumor Pressures that Exist In Vivo

DiResta, G. R., Nathan, S. S., Manoso, M. W., Casas-Ganem, J., Wyatt, C., Kubo, T., Boland, P. J., Athanasian, E. A., Miodownik, J., Gorlick, R., et al. (2005) · Annals of Biomedical Engineering

Cellular Mechanics and InteractionsCancer Cells and Metastasis

Cited by 51

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance

Humeniuk, R., Menon, L. G., Mishra, P. J., Gorlick, R., Sowers, R., Rode, W., Pizzorno, G., Cheng, Y.-C., Kemeny, N., Bertino, J. R., et al. (2009) · Molecular Cancer Therapeutics

Biochemical and Molecular ResearchColorectal Cancer Treatments and Studies

Cited by 50

ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

Hingorani, P., Roth, M. E., Wang, Y., Zhang, W., Gill, J. B., Harrison, D. J., Teicher, B., Erickson, S., Gatto, G., Smith, M. A., et al. (2021) · Molecular Cancer Therapeutics

Sarcoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research

Cited by 41

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Wang, Y., Tian, X., Zhang, W., Zhang, Z., Lazcano, R., Hingorani, P., Roth, M. E., Gill, J. D., Harrison, D. J., Xu, Z., et al. (2022) · Molecular Cancer Therapeutics

Sarcoma Diagnosis and TreatmentAdvanced Proteomics Techniques and Applications

Cited by 37

Initial Testing (Stage 1) of MK‐8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program

Kang, M. H., Reynolds, C. P., Kolb, E. A., Gorlick, R., Carol, H., Lock, R., Keir, S. T., Maris, J. M., Wu, J., Lyalin, D., et al. (2016) · Pediatric Blood & Cancer

Cancer-related Molecular PathwaysCancer Mechanisms and Therapy

Cited by 36

Trastuzumab Deruxtecan, Antibody–Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium

Hingorani, P., Zhang, W., Zhang, Z., Xu, Z., Wang, W.-L., Roth, M. E., Wang, Y., Gill, J. B., Harrison, D. J., Teicher, B. A., et al. (2022) · Molecular Cancer Therapeutics

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 28

Initial testing of JNJ‐26854165 (Serdemetan) by the pediatric preclinical testing program

Smith, M. A., Gorlick, R., Kolb, E. A., Lock, R., Carol, H., Maris, J. M., Keir, S. T., Morton, C. L., Reynolds, C. P., Kang, M. H., et al. (2012) · Pediatric Blood & Cancer

Cancer-related Molecular PathwaysAcute Lymphoblastic Leukemia research

Cited by 26

Abstract LB-217: Preclinical evaluation of trastuzumab deruxtecan (T-DXd; DS-8201a), a HER2 antibody-drug conjugate, in pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC)

Hingorani, P., Zhang, W., Kurmasheva, R., Zhang, Z., Wang, Y., Xu, Z., Roth, M., Gill, J., Harrison, D., Erickson, S., et al. (2020) · Cancer Research

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 6

Poverty, race, ethnicity, and survival among U.S. children with non-metastatic osteosarcoma treated on EURAMOS-1: A report from the Children’s Oncology Group.

Ilcisin, L. A. S., Han, R., Krailo, M. D., Gorlick, R. G., Nadel, H. R., Binitie, O., Janeway, K. A., & Bona, K. (2022) · Journal of Clinical Oncology

Sarcoma Diagnosis and TreatmentGlobal Cancer Incidence and Screening

Cited by 5